Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy
Heart failure (HF) is a common and serious comorbidity of diabetes. Oxidative stress has been associated with the pathogenesis of chronic diabetic complications including cardiomyopathy. The ability of antioxidants to inhibit injury has raised the possibility of new therapeutic treatment for diabeti...
Main Authors: | Xue Zhao, Xiaohua Lu, Guoguang Wang, Wei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Touch Medical Media
2011-09-01
|
Series: | Heart International |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/hi/article/view/2663 |
Similar Items
-
Is Environmental Cadmium Exposure Causally Related to Diabetes and Obesity?
by: Soisungwan Satarug
Published: (2023-12-01) -
Systemic hemin therapy attenuates blood–brain barrier disruption after intracerebral hemorrhage
by: Xiangping Lu, et al.
Published: (2014-10-01) -
Spotlight on a New Heme Oxygenase Pathway: Testosterone-Induced Shifts in Cardiac Oxidant/Antioxidant Status
by: Renáta Szabó, et al.
Published: (2019-08-01) -
Immune Modulation by Inhibitors of the HO System
by: Ayleen Fernández-Fierro, et al.
Published: (2020-12-01) -
Heme Degradation in Pathophysiology of and Countermeasures to Inflammation-Associated Disease
by: Donald David Haines, et al.
Published: (2020-12-01)